Terms: = Gastric cancer AND TPR, P12270, 7175
24 results:
1. Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for gastric cancer Harboring
Wang C; Li J; Qu L; Tang X; Song X; Yang F; Chen X; Lin Q; Lin W; Zhou Y; Tu Z; Chen Y; Zhang Z; Lu X
J Med Chem; 2022 Nov; 65(22):15140-15164. PubMed ID: 36355693
[No Abstract] [Full Text] [Related]
2. Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis.
Liu T; Liu D; Jin Y; Dong M
Immunopharmacol Immunotoxicol; 2022 Dec; 44(6):809-815. PubMed ID: 35708278
[TBL] [Abstract] [Full Text] [Related]
3. Segmentation of gastric Computerized Tomography Images under Intelligent Algorithms in Evaluation of Efficacy of Decitabine Combined with Paclitaxel in Treatment of gastric cancer.
Ge Z; Wang M; Liu Q
J Healthc Eng; 2021; 2021():8023490. PubMed ID: 34745511
[TBL] [Abstract] [Full Text] [Related]
4. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience.
Allen CJ; Blumenthaler AN; Smith GL; Das P; Minsky BD; Blum M; Ajani J; Mansfield PF; Ikoma N; Badgwell BD
Ann Surg Oncol; 2021 Feb; 28(2):758-765. PubMed ID: 32696305
[TBL] [Abstract] [Full Text] [Related]
5. Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).
Atiq MA; Davis JL; Hornick JL; Dickson BC; Fletcher CDM; Fletcher JA; Folpe AL; Mariño-Enríquez A
Mod Pathol; 2021 Jan; 34(1):95-103. PubMed ID: 32669612
[TBL] [Abstract] [Full Text] [Related]
6. Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.
Willis J; Lefterova MI; Artyomenko A; Kasi PM; Nakamura Y; Mody K; Catenacci DVT; Fakih M; Barbacioru C; Zhao J; Sikora M; Fairclough SR; Lee H; Kim KM; Kim ST; Kim J; Gavino D; Benavides M; Peled N; Nguyen T; Cusnir M; Eskander RN; Azzi G; Yoshino T; Banks KC; Raymond VM; Lanman RB; Chudova DI; Talasaz A; Kopetz S; Lee J; Odegaard JI
Clin Cancer Res; 2019 Dec; 25(23):7035-7045. PubMed ID: 31383735
[TBL] [Abstract] [Full Text] [Related]
7. TRP channels in gastric cancer: New hopes and clinical perspectives.
Sterea AM; Egom EE; El Hiani Y
Cell Calcium; 2019 Sep; 82():102053. PubMed ID: 31279156
[TBL] [Abstract] [Full Text] [Related]
8. The impact of advanced age on short-term outcomes following gastric cancer resection: an ACS-NSQIP analysis.
Hamilton TD; Mahar AL; Haas B; Beyfuss K; Law CHL; Karanicolas PJ; Coburn NG; Hallet J
Gastric Cancer; 2018 Jul; 21(4):710-719. PubMed ID: 29230588
[TBL] [Abstract] [Full Text] [Related]
9. Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for gastric cancer: A Multicenter Retrospective Study.
Yamashita K; Kurokawa Y; Yamamoto K; Hirota M; Kawabata R; Mikami J; Masuzawa T; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2017 Sep; 24(9):2639-2645. PubMed ID: 28608116
[TBL] [Abstract] [Full Text] [Related]
10. KATZLDA: KATZ measure for the lncRNA-disease association prediction.
Chen X
Sci Rep; 2015 Nov; 5():16840. PubMed ID: 26577439
[TBL] [Abstract] [Full Text] [Related]
11. A novel interaction between interferon-inducible protein p56 and ribosomal protein L15 in gastric cancer cells.
Hsu YA; Lin HJ; Sheu JJ; Shieh FK; Chen SY; Lai CH; Tsai FJ; Wan L; Chen BH
DNA Cell Biol; 2011 Sep; 30(9):671-9. PubMed ID: 21612406
[TBL] [Abstract] [Full Text] [Related]
12. Designed hybrid tpr peptide targeting Hsp90 as a novel anticancer agent.
Horibe T; Kohno M; Haramoto M; Ohara K; Kawakami K
J Transl Med; 2011 Jan; 9():8. PubMed ID: 21235734
[TBL] [Abstract] [Full Text] [Related]
13. Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon.
Lee S; Bang S; Song K; Lee I
Oncol Rep; 2006 Oct; 16(4):747-54. PubMed ID: 16969489
[TBL] [Abstract] [Full Text] [Related]
14. RNAi technology and lentiviral delivery as a powerful tool to suppress tpr-Met-mediated tumorigenesis.
Taulli R; Accornero P; Follenzi A; Mangano T; Morotti A; Scuoppo C; Forni PE; Bersani F; Crepaldi T; Chiarle R; Naldini L; Ponzetto C
Cancer Gene Ther; 2005 May; 12(5):456-63. PubMed ID: 15719029
[TBL] [Abstract] [Full Text] [Related]
15. Identification and characterization of TPARM gene in silico.
Katoh M; Katoh M
Int J Oncol; 2003 Oct; 23(4):1213-7. PubMed ID: 12964006
[TBL] [Abstract] [Full Text] [Related]
16. K252a inhibits the oncogenic properties of Met, the HGF receptor.
Morotti A; Mila S; Accornero P; Tagliabue E; Ponzetto C
Oncogene; 2002 Jul; 21(32):4885-93. PubMed ID: 12118367
[TBL] [Abstract] [Full Text] [Related]
17. Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma.
Heideman DA; Snijders PJ; Bloemena E; Meijer CJ; Offerhaus GJ; Meuwissen SG; Gerritsen WR; Craanen ME
J Pathol; 2001 Aug; 194(4):428-35. PubMed ID: 11523050
[TBL] [Abstract] [Full Text] [Related]
18. Frequency of tpr-MET rearrangement in patients with gastric carcinoma and in first-degree relatives.
Yu J; Miehlke S; Ebert MP; Hoffmann J; Breidert M; Alpen B; Starzynska T; Stolte Prof M; Malfertheiner P; Bayerdörffer E
Cancer; 2000 Apr; 88(8):1801-6. PubMed ID: 10760755
[TBL] [Abstract] [Full Text] [Related]
19. Loss of heterozygosity and homozygous deletion of the tpr locus in human gastric cancer.
Cunningham JD; Schwartz GK; Karpeh M; Blundell M; Kelson DP; Jhanwar SC; Albino AP
Am J Surg; 1997 Jun; 173(6):521-2. PubMed ID: 9207167
[TBL] [Abstract] [Full Text] [Related]
20. Lack of rearranged tpr-met mRNA expression in human gastric cancer cell lines and gastric mucosa and carcinoma.
Osaki M; Miyata H; Hayashi A; Gomyo Y; Tatebe S; Ito H
Anticancer Res; 1996; 16(5A):2881-4. PubMed ID: 8917402
[TBL] [Abstract] [Full Text] [Related]
[Next]
